Hypertension:
Indications for: Hydralazine Tablets
Hypertension.
Adult Dosage:
Initially 10mg 4 times daily for 2–4 days, then increase to 25mg 4 times daily for rest of 1st week, then to 50mg 4 times daily; max 300mg/day.
Children Dosage:
Initially 0.75mg/kg per day in 4 divided doses, increase gradually over 3–4 weeks; max 7.5mg/kg or 200mg daily.
Hydralazine Tablets Contraindications:
Coronary artery disease. Mitral valve disease.
Hydralazine Tablets Warnings/Precautions:
Suspected coronary artery disease. Cerebrovascular accidents. Aortic aneurysm. Increased intracranial pressure. Renal disease. Treat paresthesias and/or numbness with pyridoxine. Discontinue if blood dyscrasias occur. Obtain CBC and ANA titer periodically; consider discontinuing if SLE occurs. Surgery. Pregnancy (Cat.C). Nursing mothers.
See Also:
Hydralazine Tablets Classification:
Vasodilator.
Hydralazine Tablets Interactions:
Caution with MAOIs. Profound hypotension with potent parenteral antihypertensives (eg, diazoxide). Antagonized by NSAIDs. May block epinephrine.
Adverse Reactions:
Headache, anorexia, GI disturbances, palpitations, edema, flushing, nasal congestion, lacrimation, rash, tachycardia, angina, orthostatic hypotension, blood dyscrasias, peripheral neuritis, SLE.
Note:
Formerly known under the brand names Apresoline (inj, tabs); Dralzine (tabs).
How Supplied:
Contact supplier.
